Hodecker, S. C., Stürner, K. H., Becker, V., Elias-Hamp, B., Holst, B., Friese, M. A., & Heesen, C. (2017). Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS. Neurol Neuroimmunol Neuroinflamm.

Hodecker, Sibylle C., Klarissa H. Stürner, Veit Becker, Birte Elias-Hamp, Brigitte Holst, Manuel A. Friese, und Christoph Heesen. "Maraviroc As Possible Treatment for PML-IRIS in Natalizumab-treated Patients With MS." Neurol Neuroimmunol Neuroinflamm 2017.

Hodecker, Sibylle C., et al. "Maraviroc As Possible Treatment for PML-IRIS in Natalizumab-treated Patients With MS." Neurol Neuroimmunol Neuroinflamm 2017.